Earnings Call · Q4 FY2023·2024-02-22

Q4 23EPS -8.00%·Rev n/aQ3 23EPS +14.55%·Rev n/aQ2 23EPS +3.70%·Rev n/aQ1 23EPS +6.84%·Rev n/a⚠ consensus missing

Arcus Biosciences, Inc. RCUS

Pia Eaves — Vice President of Investor Relations

Terry Rosen — Chief Executive Officer

Jennifer Jarrett — Chief Financial Officer

Dimitry Nuyten — Senior Clinical Development Executive

Bob Goeltz — Chief Financial Officer or Senior Finance Executive

+19.9%1d on move date+17.8% vs SPY3d+19.8%5d+16.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCUS calls or request research access.

More RCUS calls Browse calls Request research access